Based in Mountain View, CA., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differential RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source.
At NeuroPace, employees are our greatest asset. We are continually searching for solution-oriented individuals who can bring energy and creativity to our growing workforce. At NeuroPace, our success depends upon our ability to recruit and retain the most talented, enthusiastic and dedicated people we can find and providing them with a dynamic and challenging environment in which to thrive.
We are currently seeking a Sr. Manager, Risk & Post-Market Surveillance (TPLC) to join our team.
About the role
We are seeking an experienced middle management leader to drive post-commercialization risk management and data-driven safety analytics as part of our quality system. The role serves as a key resource in evaluating and improving risk management programs to ensure alignment with applicable regulations and standards and to inform total product life cycle efforts. The role involves assessment & analysis, planning, documentation, and recommendation of remediation & improvement activities across product design and quality systems.
What you'll do
- Serve as a subject matter expert in post-commercialization risk management processes and data-driven safety analytics.
- Lead cross-functional efforts and meetings to analyze and synthesize complex data into actionable insights for senior leadership and other key stakeholders to drive total product lifecycle improvements through the product development pipeline.
- Maintain ISO 14971-compliant risk files, developing global Post-Market Surveillance plans, and leverage advanced statistical tools to detect emerging performance signals.
- Implement, instruct, and, where applicable, support training of staff on risk management remediation directives based on findings and analysis with a strong focus on post-market field use of product(s).
- Ensure all ongoing maintenance, continuous improvement and remediation efforts meet applicable quality and regulatory standards.
- Drive change across the organization to ensure cross-functional stakeholders align and integrate recommended risk remediation activities based on data-driven analysis.
What you will bring
- Bachelor’s degree in engineering (software engineering preferred) with experience in statistics
- Master’s degree in related field (Engineering, Statistics, or Analytics) or equivalent job experience
- Minimum of 5+ years of experience in medical device risk management.
- Strong working knowledge of FDA, EU MDR and IMDRF PMS regulations, including international standards such as ISO 14971, ISO 13485, FDA 21 CFR Part 803/ 820.
- Proficiency in statistical analysis and visualization tools (such as MS Power BI, R, JMP, JAMA, Minitab, SAS, or Python).
- Proven experience interpreting post-commercialization product use data and planning total quality systems response(s) to findings.
- Strong technical writing, communication, and project management skills.
- Ability to work independently and as part of a cross-functional team.
Why Join Us
- Be a key safety and compliance driver in a company committed to improving patient outcomes.
- Own a high-visibility position with impact across the organization.
- Work in a collaborative, forward-thinking environment where data-driven insights shape product strategy and patient care.
$160K-$210K Base - Compensation will be determined based on several factors, including but not limited to skill set, years of experience, and geographic location.
NeuroPace is proud to be an equal opportunity employer and values the contributions of our culturally diverse workforce.San Francisco and Los Angeles applicants: The Company will consider for employment qualified applicants with Criminal Histories in a manner consistent with the requirements of the Los Angeles Fair Chance in Hiring Ordinance or the San Francisco Fair Chance Ordinance (as applicable)
Benefits
- Medical, Dental & Vision Insurance
- Voluntary Life
- 401K
- RSU
- 529 plan
- ESPP Program
- Health & Wellness Program
- Generous Paid Time Off plus eleven paid holidays
- FSA & Commuter Benefits
NeuroPace is proud to be an equal opportunity employer and values the contributions of our culturally diverse workforce.
San Francisco and Los Angeles applicants: The Company will consider for employment qualified applicants with Criminal Histories in a manner consistent with the requirements of the Los Angeles Fair Chance in Hiring Ordinance or the San Francisco Fair Chance Ordinance (as applicable)
PRIVACY NOTICE: NeuroPace takes its responsibility to protect your personal information seriously, and it uses reasonable safeguards to avoid unauthorized use or disclosure of it, and inadvertent loss or impermissible alteration of it. NeuroPace complies with all applicable federal and state laws and regulations that govern the handling of your personal information. If you would like more detailed information on NeuroPace’s privacy policies, please refer to neuropace.com/privacy/ for reference. NeuroPace retains candidate resumes and applications in its files for future reference and/or consideration for other available job postings. If you do not wish for your resume and applications materials to be retained in NeuroPace files, or wish to obtain a listing of any personal information that NeuroPace has stored about you, please contact us at [email protected].
Similar Jobs
.jpeg)
What We Do
The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
